Abstract:Transforming growth factor (TGF)-β 1 is an important cytokine involved in various diseases. However, the molecular mechanism whereby TGF-β 1 signaling modulates the regulatory network for smooth muscle gene transcription remains largely unknown. To address this question, we previously identified a Smad-binding element (SBE) in the SM22α promoter as one of the TGF-β 1 response elements. Here, we show that mutation of the SBE reduces the activation potential of a SM22α promoter in transgenic mice during embryogenesis. Chromatin immunoprecipitation assays reveal that TGF-β 1 induces Smad3 binding to the SM22α promoter in vivo. A multimerized SBE promoter responsive to TGF-β 1 signaling is highly activated by Smad3 but not by the closely related Smad2. Intriguingly, myocardin (Myocd), a known CArG box-dependent serum response factor coactivator, participates in Smad3-mediated TGF-β 1 signaling and synergistically stimulates Smad3-induced SBE promoter activity independent of the CArG box; no such synergy is seen with Smad2. Importantly, Myocd cooperates with Smad3 to activate the wild-type SM22α, SM myosin heavy chain, and SMα-actin promoters; they also activate the CArG box-mutated SM22α promoter as well as the CArG box-independent aortic carboxypeptidase-like protein promoter. Immunopreciptiation assays reveal that Myocd and Smad3 directly interact both in vitro and in vivo. Mutagenesis studies indicate that the C-terminal transactivation domains of Myocd and Smad3 are required for their functional synergy. These results reveal a novel regulatory mechanism whereby Myocd participates in TGF-β 1 signal pathway through direct interaction with Smad3, which binds to the SBEs. This is the first demonstration that Myocd can act as a transcriptional coactivator of the smooth muscle regulatory network in a CArG box-independent manner.

Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts As a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*

Smad3 and Smad4 Cooperate with C-Jun/c-fos to Mediate TGF-β-induced Transcription

Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor β (TGF-β)-induced Activation of Smad7

Analysis of the DNA-binding properties of TGF-β-activated Smad complexes unveils a possible molecular basis for cellular context-dependent signaling

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

Xenopus Smad4β is the Co-Smad Component of Developmentally Regulated Transcription Factor Complexes Responsible for Induction of Early Mesodermal Genes

Smad1 Interacts with Homeobox DNA-binding Proteins in Bone Morphogenetic Protein Signaling

Smad6 as a Transcriptional Corepressor

Receptor-activated transcription factors and beyond: multiple modes of Smad2/3-dependent transmission of TGF-β signaling

Regulation Of Smad Signaling Through A Differential Recruitment Of Coactivators And Corepressors By Zeb Proteins

Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter.

Smad6 Recruits Transcription Corepressor CtBP to Repress Bone Morphogenetic Protein-Induced Transcription.

Myocardin Enhances Smad3-Mediated Transforming Growth Factor-β 1 Signaling in a CArG Box-Independent Manner

Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2.

Promoting Bone Morphogenetic Protein Signaling Through Negative Regulation of Inhibitory Smads

Smad2 and Smad3 Have Differential Sensitivity in Relaying TGFβ Signaling and Inversely Regulate Early Lineage Specification

Activation of c-Jun NH2-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor

Review of Current Progress in the Structure and Function of Smad Proteins.